Sign Up Today and Learn More About Inari Stock
Invest in or calculate the value of your shares in Inari or other pre-IPO companies through EquityZen's platform.
Inari Stock
Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment.
About Inari Stock
Founded
2016
Headquarters
Cambridge, MA, US
Notable Investor
G Squared
Industries
Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment. It embraces diversity in every aspect of its business to drive innovation and help build a new food system. The company's technology matches the complexity of nature using predictive design and multiplex gene editing to unlock the full potential of the seed. Inari's SEEDesign platform is their point of distinction, using unsurpassed technology to enhance any crop for any geography to develop step-change products with a clear go-to-market approach. It was founded in 2016 and is based in Cambridge, MA.
Inari Press Mentions
Stay in the know about the latest news on Inari
The 10 Biggest Rounds Of January: Generate Capital, Recurrent Energy Top First Month Of Year
news • Feb, 7 2024
Inari raises another $103M for gene-editing technology
insideindianabusiness • Feb, 6 2024
The Week’s 10 Biggest Funding Rounds: Generate Capital Goes Big Again, Kore.ai Nabs $150M
news • Feb, 2 2024
Inari Closes on $103M Series F For its SEEDesign™ Platform
globalaginvesting • Feb, 1 2024
Seed gene-editing startup Inari valued at $165bn following $103m fundraise
agfundernews • Feb, 1 2024
Investors in Inari
Discover investors in Inari stock and explore their portfolio companies
Inari Management
Leadership team at Inari
CEO and Director
Ponsi Trivisvavet
Chief Scientific Officer
Catherine Feuillet
Join now and verify your accreditation status to gain access to:
- Inari current valuation
- Inari stock price
- Available deals in Inari and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Inari stock?
Accredited investors can buy pre-IPO stock in companies like Inari through EquityZen funds. These investments are made available by existing Inari shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Inari stock?
Shareholders can sell their Inari stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."